This is the authors' abstract. We don't add key points for this paper.
Antibodies to merozoite surface antigens (MSPs), the primary targets of malaria vaccine research, are associated with low malaria morbidity. However, few studies have looked at the implications of their variations on the evolution of clinical-biological forms of severe malaria.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Shinga et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: